Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-03-08 @ 1:46 AM
Study NCT ID:
NCT05909618
Status:
RECRUITING
Last Update Posted:
2025-07-22
First Post:
2023-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Sponsor:
Organization: